Skeletal Dysplasia Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The global skeletal dysplasia
market is anticipated to grow with a modest growth rate during the forecast
period. The skeletal dysplasia disorder is a heterogeneous group of more than
350 disorders found in both adults and children. Skeletal dysplasia is
frequently associated with orthopedic complications and varying degrees of
dwarfism or short stature.
It is a rare disease and is observed in 2.4 per 10,000 births (as per the Johns Hopkins University). Skeletal dysplasia disorder also affects significant number of young children. The severity of the disorder is very high in children as along with the various orthopedic problems they also suffer from a frequent chest infection, hearing, and breathing difficulty. The growth of the skeletal dysplasia market is attributed to the advancements in the understanding of the pathophysiology of skeletal dysplasia that is propelling the efforts in treatment strategies. Additionally, emerging new advanced drug therapy for the treatment of skeletal dysplasia will also fuel the skeletal dysplasia market industry.
To Request a Sample of our Report on Skeletal Dysplasia Market: https://www.omrglobal.com/request-sample/skeletal-dysplasia-market
These increasing variety of
medical and surgical treatment options for the treatment of skeletal dysplasia
is aiding significantly to the improved quality of life and increased lifespan
of the patients. Since the quality of life is severely affected by spinal and
orthopedic disorders. Hence, a considerable increase in the adoption of
treatment is anticipated during the forecast period.
Moreover, the skeletal dysplasia disorder’s diagnosis based on various radiographic, clinical, and molecular criteria and the continuous improvement in the clinical diagnosis is increasing the number of diagnosed cases. This in turn is fuelling the skeletal dysplasia growth. For instance, in December 2019, Invitae Corp. launched “Discover Dysplasias”. It is an initiative with BioMarin Pharmaceutical Inc. for genetic testing at no charge to patients with symptoms of having a skeletal dysplasia. Furthermore, several surgical therapies are also being attempted to correct bone deformities in patients with skeletal dysplasia. In addition to this, the increasing number of clinical trials of growth hormone (GH) therapy for patients with skeletal dysplasia disorder is anticipated to considerably drive the skeletal dysplasia market.
A full
Report of Skeletal Dysplasia Market is Available at: https://www.omrglobal.com/industry-reports/skeletal-dysplasia-market
·
Achondroplasia
·
Thanatophoric dysplasia
·
Hypochondroplasia
·
Others
By
Treatment
·
Medications
·
Therapy
·
Others (Surgery)
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest oF APAC
Rest of The
World
·
Latin
America
·
Middle
East Africa
Company
Profiles
·
Alexion
Pharmaceuticals, Inc.
·
Amgen
Inc.
·
Ascendis
Pharma A/S
·
BioMarin
Pharmaceutical Inc.
·
Invitae
Corp.
·
Ipsen
Pharma
·
Merck
KGaA
·
Novartis
AG
·
Novo
Nordisk A/S
·
Pfizer
Inc.
·
Pharmaceuticals
Inc.
·
Thermo
Fisher Scientific Inc.
Reasons to Buying
From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/skeletal-dysplasia-market
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment